CY1106557T1 - Πρωτοτυπο πεπτιδιο που εμφανιζει ανασταλτικη επιδραση επι της κονβερτασης αγγειοτενσινης - Google Patents

Πρωτοτυπο πεπτιδιο που εμφανιζει ανασταλτικη επιδραση επι της κονβερτασης αγγειοτενσινης

Info

Publication number
CY1106557T1
CY1106557T1 CY20071100587T CY071100587T CY1106557T1 CY 1106557 T1 CY1106557 T1 CY 1106557T1 CY 20071100587 T CY20071100587 T CY 20071100587T CY 071100587 T CY071100587 T CY 071100587T CY 1106557 T1 CY1106557 T1 CY 1106557T1
Authority
CY
Cyprus
Prior art keywords
inhibiting effects
peptide exhibiting
angiotensin conversion
prototype peptide
angiotensin
Prior art date
Application number
CY20071100587T
Other languages
English (en)
Inventor
Yoshitaka Tamura
Hiroshi Miyakawa
Akio Yamada
Hitoshi Saito
Yasushi Kawaguchi
Hiroshi Ochi
Tomoko Ide
Eri Inoue
Original Assignee
Morinaga Milk Industry Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19167543&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1106557(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Morinaga Milk Industry Co., Ltd filed Critical Morinaga Milk Industry Co., Ltd
Publication of CY1106557T1 publication Critical patent/CY1106557T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Πεπτίδιο Met-Lys-Pro, το οποίο λαμβάνεται μέσω χημικής σύνθεσης ή υδρόλυσης της καζεΐνης, χρησιμοποιείται ως δραστικό συστατικό αναστολέων ενζύμου μετατροπής αγγειοτενσίνης ή υποτασικών φαρμάκων.
CY20071100587T 2001-11-21 2007-05-03 Πρωτοτυπο πεπτιδιο που εμφανιζει ανασταλτικη επιδραση επι της κονβερτασης αγγειοτενσινης CY1106557T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001355923 2001-11-21
PCT/JP2002/012197 WO2003044044A1 (fr) 2001-11-21 2002-11-21 Nouveau peptide exerçant un effet inhibiteur d'angiotensine convertase

Publications (1)

Publication Number Publication Date
CY1106557T1 true CY1106557T1 (el) 2012-01-25

Family

ID=19167543

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100587T CY1106557T1 (el) 2001-11-21 2007-05-03 Πρωτοτυπο πεπτιδιο που εμφανιζει ανασταλτικη επιδραση επι της κονβερτασης αγγειοτενσινης

Country Status (19)

Country Link
US (1) US7022676B2 (el)
EP (1) EP1457498B9 (el)
JP (1) JP3816921B2 (el)
KR (1) KR100615844B1 (el)
CN (1) CN1240711C (el)
AT (1) ATE353336T1 (el)
AU (1) AU2002366037B2 (el)
BR (1) BR0214299A (el)
CA (1) CA2468039C (el)
CY (1) CY1106557T1 (el)
DE (1) DE60218064T2 (el)
DK (1) DK1457498T3 (el)
ES (1) ES2281567T3 (el)
HK (1) HK1076114A1 (el)
MX (1) MXPA04004805A (el)
NO (1) NO328611B1 (el)
NZ (1) NZ533544A (el)
PT (1) PT1457498E (el)
WO (1) WO2003044044A1 (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101115560B1 (ko) 2003-08-01 2012-03-13 칼피스가부시키가이샤 생체내 비분해성 펩티드, 안지오텐신 변환효소 저해제, 의약 및 기능성 식품
CN1894273B (zh) * 2003-12-01 2011-01-12 明治乳业株式会社 血管紧张素转化酶抑制肽
CN102304169B (zh) * 2011-08-05 2013-03-20 成都中医药大学 降血压多肽及其用途
CN102276690B (zh) * 2011-08-05 2013-03-20 成都中医药大学 降血压功能性多肽及其用途
WO2013125622A1 (ja) * 2012-02-22 2013-08-29 森永乳業株式会社 ジペプチジルペプチダーゼ－ｉｖ阻害剤
JP5832049B2 (ja) 2012-03-09 2015-12-16 森永乳業株式会社 ジペプチジルペプチダーゼ−ｉｖ阻害剤
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
JP6344796B2 (ja) * 2014-09-30 2018-06-20 森永乳業株式会社 高齢者用アルツハイマー型認知症改善剤
JP2018057346A (ja) * 2016-10-07 2018-04-12 森永乳業株式会社 カゼイン酵素処理物及びその製造方法
CN107337710A (zh) * 2017-07-26 2017-11-10 盐城卫生职业技术学院 一种抗高血压活性肽The‑The‑Pro及应用和药物组合物
JP7358239B2 (ja) 2017-09-19 2023-10-10 森永乳業株式会社 エネルギー消費促進用組成物
EP3753569A4 (en) 2018-02-16 2021-12-15 Morinaga Milk Industry Co., Ltd. COMPOSITION FOR LOWERING BLOOD PRESSURE AND / OR FOR LOWERING NEUTRAL FATS
JP6589011B2 (ja) * 2018-05-17 2019-10-09 森永乳業株式会社 脳機能障害改善用経口組成物
CN113321719B (zh) * 2021-05-20 2022-03-18 澳优乳业（中国）有限公司 一种寡肽及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07313185A (ja) * 1992-08-20 1995-12-05 Marino Forum 21 ぺプチドの製造方法
JP3040389B2 (ja) * 1999-01-18 2000-05-15 日本合成化学工業株式会社 ペプチドの製造法

Also Published As

Publication number Publication date
KR20050044541A (ko) 2005-05-12
ATE353336T1 (de) 2007-02-15
CN1612892A (zh) 2005-05-04
NO20042601L (no) 2004-08-18
US20050004041A1 (en) 2005-01-06
US7022676B2 (en) 2006-04-04
AU2002366037A1 (en) 2003-06-10
PT1457498E (pt) 2007-05-31
CN1240711C (zh) 2006-02-08
DK1457498T3 (da) 2007-06-04
NO328611B1 (no) 2010-03-29
EP1457498B1 (en) 2007-02-07
EP1457498B9 (en) 2009-09-02
JPWO2003044044A1 (ja) 2005-03-10
DE60218064D1 (de) 2007-03-22
ES2281567T3 (es) 2007-10-01
JP3816921B2 (ja) 2006-08-30
CA2468039C (en) 2011-01-04
KR100615844B1 (ko) 2006-08-25
BR0214299A (pt) 2004-12-14
NZ533544A (en) 2005-02-25
EP1457498A1 (en) 2004-09-15
EP1457498A4 (en) 2005-10-19
HK1076114A1 (en) 2006-01-06
WO2003044044A1 (fr) 2003-05-30
CA2468039A1 (en) 2003-05-30
DE60218064T2 (de) 2007-11-15
MXPA04004805A (es) 2004-08-11
AU2002366037B2 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
CY1106557T1 (el) Πρωτοτυπο πεπτιδιο που εμφανιζει ανασταλτικη επιδραση επι της κονβερτασης αγγειοτενσινης
DE602004017325D1 (de) (2s,4s)-4-fluor-1-ä4-fluor-beta-(4-fluorphenyl)-l-phenylalanylü-2-pyrrolidincarbonitril-p-toluolsulfonsäuresalz und wasserfreie kristalline formen davon
BRPI0414593A (pt) derivados de ácido sulfonamida substituìda-indol-2-carboxìlico como inibidores de pai-1
NO20091976L (no) Nye forbindelser
NO20034289D0 (no) N-(2-aryletylbenzylaminer som antagonister av 5-HT6- reseptoren
BR9902086A (pt) Formulações farmacêuticas.
CY1107383T1 (el) Αναστολεις της φωσφολιπασης α2 του κυτοπλασμικου διαλυματος
DE602004006433D1 (de) Pyrrol-substituierte indole als inhibitoren von pai-1
DE60228071D1 (de) Spiropyrazol-verbindungen
ATE435648T1 (de) Derivaten von nodulisporen säure
PT1473036E (pt) Solvato de hemitartarato de zolpidem
NO20026242D0 (no) Syntesemetoder for aplidin og nye antitumorale derivater, metoder for fremstilling og anvendelse av disse
NO20031930L (no) Tripeptidylpeptidaseinhibitorer
CY1105980T1 (el) Βελτιωμενη διαδικασια παρασκευης υδροβρωμικου αλατος του αλφα-πολυμορφικου ελετριπτανιου
BR0313969A (pt) Inibidores de oxitocina
EA200201138A1 (ru) Пептид, модулирующий рецептор тромбопоэтина
DE60327936D1 (de) Modulatoren von ship-1
NO20015892D0 (no) Inhibitorer av metallproteinaser
MXPA05011783A (es) Peptidos que tienen un efecto inhibidor de enzima convertidora de angiotensina.
NO20051301L (no) Proteintyrosinforfataseinhibitorer
ATE374775T1 (de) Inhibitoren des hiv-integrase-enzyms
DE69930844D1 (de) Inhibitoren von mycobakterien
NO20024679D0 (no) Krystallinsk farmasöytikum
EA200601086A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
DE50212676D1 (de) Exopolysaccharidproduktion